Yuki Kageyama to Cell Survival
This is a "connection" page, showing publications Yuki Kageyama has written about Cell Survival.
Connection Strength
0.225
-
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer. Anticancer Res. 2026 May; 46(5):2445-2453.
Score: 0.204
-
Development of a novel interferon-a2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro. Int J Clin Oncol. 2014; 19(3):497-504.
Score: 0.021